283 related articles for article (PubMed ID: 31795959)
1. Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience.
Gonnet A; Salabert L; Roubaud G; Catena V; Brouste V; Buy X; Gross Goupil M; Ravaud A; Palussière J
BMC Cancer; 2019 Dec; 19(1):1182. PubMed ID: 31795959
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
3. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
[TBL] [Abstract][Full Text] [Related]
6. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Sawayama H; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Kawanaka K; Yamashita Y; Baba H
Int J Clin Oncol; 2019 Mar; 24(3):288-295. PubMed ID: 30328530
[TBL] [Abstract][Full Text] [Related]
7. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
9. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
[TBL] [Abstract][Full Text] [Related]
10. Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation.
Hasegawa T; Kuroda H; Sakakura N; Sato Y; Chatani S; Murata S; Yamaura H; Nakada T; Oya Y; Inaba Y
Thorac Cancer; 2021 Jul; 12(14):2085-2092. PubMed ID: 34106518
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience.
Fanucchi O; Ambrogi MC; Aprile V; Cioni R; Cappelli C; Melfi F; Massimetti G; Mussi A
Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):57-64. PubMed ID: 27059068
[TBL] [Abstract][Full Text] [Related]
12. Safety, efficacy and predictors of local recurrence after percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma.
Su MZ; Memon F; Lau HM; Brooks AJ; Patel MI; Woo HH; Bariol SV; Vladica P
Int Urol Nephrol; 2016 Oct; 48(10):1609-16. PubMed ID: 27432413
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
14. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma.
Shu Yan Huo A; Lawson Morris D; King J; Glenn D
Ann Surg Oncol; 2009 Nov; 16(11):3169-75. PubMed ID: 19680727
[TBL] [Abstract][Full Text] [Related]
15. Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.
Vogl UM; Bojic M; Lamm W; Frischer JM; Pichelmayer O; Kramer G; Haitel A; Kitz K; Harmankaya K; Zielinski CC; Schmidinger M
BMC Cancer; 2010 Sep; 10():480. PubMed ID: 20819239
[TBL] [Abstract][Full Text] [Related]
16. Reiterative Radiofrequency Ablation in the Management of Pediatric Patients with Hepatoblastoma Metastases to the Lung, Liver, or Bone.
Yevich S; Calandri M; Gravel G; Fresneau B; Brugières L; Valteau-Couanet D; Branchereau S; Chardot C; Aerts I; de Baere T; Tselikas L; Deschamps F
Cardiovasc Intervent Radiol; 2019 Jan; 42(1):41-47. PubMed ID: 30350173
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency Ablation and Radiation Therapy Improve Local Control in Spinal Metastases Compared to Radiofrequency Ablation Alone.
Prezzano KM; Prasad D; Hermann GM; Belal AN; Alberico RA
Am J Hosp Palliat Care; 2019 May; 36(5):417-422. PubMed ID: 30541334
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.
de Baère T; Aupérin A; Deschamps F; Chevallier P; Gaubert Y; Boige V; Fonck M; Escudier B; Palussiére J
Ann Oncol; 2015 May; 26(5):987-991. PubMed ID: 25688058
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes and prognostic factors of cone-beam CT-guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients.
Hong HP; Kim HO; Koo DH; Lee YG; Kim MS; Ham SY; Kang DY; Oh TY; Lee H; Jung KU; Kim H
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e215-e222. PubMed ID: 35822242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
